Antibacterial activity of ethanolic and aqueous extracts of four medicinal plants on the in vitro growth of Escherichia coli and Staphylococcus aureus by KOKORA, Aya philomÃ¨ne
KOKORA et al                                 Journal of Drug Delivery & Therapeutics; 2013, 3(3), 113-116 113 
© 2011, JDDT. All Rights Reserved                                                 ISSN: 2250-1177                                                     CODEN (USA): JDDTAO 
Available online at http://jddtonline.info 
RESEARCH ARTICLE 
ANTIBACTERIAL ACTIVITY OF ETHANOLIC AND AQUEOUS EXTRACTS OF FOUR 
MEDICINAL PLANTS ON THE IN VITRO GROWTH OF ESCHERICHIA COLI AND 
STAPHYLOCOCCUS AUREUS 
Philomène Aya KOKORA1, *Jacques Auguste Alfred Bognan ACKAH1, Zinzindorf Yessé NANGA,2 Mathieu Adou 
Koffi KRA1, Guillaume Yao LOUKOU2, Adama COULIBALY 1, Joseph DJAMAN1,3 
1Laboratoire de Pharmacodynamie – Biochimique, UFR Biosciences, Université de Cocody Abidjan, 
2UFR des Sciences Pharmaceutiques & Biologiques, Université de Cocody, Laboratoire National de la Santé Publique 
(Côte d’Ivoire) 
3Departement de biochimique clinique et fondamentale, Institut Pasteur de Côte d’Ivoire. BP490 Abidjan 01 
*Corresponding Author’s Email: jacquackah@yahoo.fr 
 
 
 
 
 
 
 
 
 
 
INTRODUCTION 
In Africa, as elsewhere in the world, plants are widely 
used in the treatment of various ailments. Adjanohoun 
and Aké1 have identified more than 5000 medicinal plant 
species. The properties of some of them have long been 
exploited by people. In the olden days in Africa priests 
and medical doctors had the ancient manuscripts 
describing many herbal recipes8. The safety, dosage and 
usage description were passed down from generation to 
generation. Thus most of the diseases known by the 
populations had a corresponding treatment. 
Today, traditional medicine rivaled with modern 
medicine despite the exploits of the latter. According to 
the World Health Organization (WHO), nearly 80% of 
people in developing countries depend on this traditional  
medicine for their primary health care needs due to the 
high cost of modern medicines 11, this is justified by the 
fact that these herbal recipes continue to show their 
efficacy in healing many people. In Côte d'Ivoire people 
using traditional medicines is increasingly high due to, 
poverty of the population, prolong political instability, 
war and access to modern medicine for health care is 
becoming increasingly difficult. 
However, knowledge of the healing power of plants by 
the people is acquired empirically 13, 14. They were 
unaware of the chemical composition of these plants and 
also various other properties they might possess. Thus, in 
order to provide a scientific justification for the 
utilization  of these plants, verification of the efficacy 
and safety of medicinal plants through 
ethnopharmacological studies have been conducted by 
several scientific groups. Four plants were selected for 
the purpose of this study, in order to verify the validity of 
anti-infective qualities assigned to them. They are: 
Erigeron floribundus, Acanthospermum spidum, 
Melanthera scadens and Terminalia mantaly. The 
antibacterial activity of total aqueous and ethanolic 
extracts of these plants was determined in vitro on the 
growth of Escherichia coli (E. Coli) and Staphylococcus 
aureus (S. Aureus). 
MATERIALS AND METHODS 
Plant material 
The leaves and bark of Erigeron floribundus 
(Asteraceae) (EF), Acanthospermum hispidum Schrank. 
(Asteraceae) (AH) Melanthera scadens Schum. & 
Thonn. (Asteraceae) (MS) and Terminalia mantaly 
H.Perrier (Combretaceae) (LYTER) were collected, 
dried and transformed into powder. All plants used in 
this study were provided by traditional healers in Côte 
d'Ivoire and identified by the National floristic Center 
University of Cocody Abidjan. The homogenates 
obtained were used in the preparation of different 
extracts. 
Microorganisms used 
The strains used for the purpose of these study are 
widely found in various human pathologies. They were 
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supplied by the National Laboratory of Public Health. Different strains are shown in Table 1. 
 
Table 1: Bacterial Strains 
 
ECBU: Urine culture, ATCC Américan Type Culture 
Collection, R: resistant, AMC: Amoxicillin + Clavulanic 
acid, PIP: Piperacillin, CF: Cephalothin, CXM: 
Cefuroxime, CMX: cefmenoxime, TM: tobramycin, 
NET netilmicin, TE : Tetracycline, SXT: + 
Trimethoprim Sulfonamides, NA: Nalidixic acid, PEF: 
pefloxacin, NOR: Norfloxacin, PT: pristinamycin, P: 
Penicillin G, L: Lincomycin, E: Erytromycine, C: 
Chloremphenicol, RA: Rifampicin, K: Kanamycin , TM: 
Tobramycin, GM: gentamicin, CIP: ciprofloxacin, AMX 
Amoxicillin ICT Tecarcilline, CTX: cefotaxime, OX: 
Oxacillin, TCC: Tticarcilline + clavulanic acid, FOS: 
Fosfomycin, CAZ: ceftazidime, ATM: aztreonam, AN: 
Amikcine, CS: Colistin. 
Preparation of extracts 
The extracts were prepared according to the method 
described by Zihiri and Kra 17. For the preparation of 
total aqueous and ethanolic extracts  70%, 100 g of plant 
powder were extracted in one liter of distilled water (or a 
mixture of ethanol - water (70/30)) by maceration using a 
magnetic agitator (the process is repeated 3 times). The 
homogenate obtained was first spun in a square of fabric, 
and then filtered twice in succession on cotton wool and 
once on Whatman 3mm paper. The filtrate was 
concentrated using a rotary evaporator at 70 ° C. The 
concentrate was evaporated at 50 ° C. in an oven for 48 
hours. The extracts obtained from the total aqueous and 
ethanolic extracts  70%. The various extracts obtained 
are: Aqueous extracts: EFaq, ASaq MSaq and 
LYTERaq; Ethanolic Extracts 70%: EFeth, Aseth, Mseth 
and LYTEReth. 
Determination of antibacterial activity 
Agar diffusion method 
The agar diffusion Muller-Hinton in agar plates was used 
to evaluate the activity of different extracts obtained. 
Culture medium has been in contact with inocula 
(prepared from pure culture of 18 to 24 hours) density of 
0.5 McFarland approximately 106 CFU / ml for 5 
minutes. The petri dishes were then dried for 15 minutes 
at 37 ° C. With sterilized object wells of 5 mm in 
diameter were punched in the agar, 6 wells maximum par 
each petri dish. 100 mg / ml extract solutions were 
prepared by diluting 100 mg of extracts in 1 ml of 
distilled water. 50 ml of each extract solution were 
distributed into the wells. The plates are then incubated 
in an oven at 37 ° C for 18 to 24 hours. 
Method of double dilution in liquid medium 
The method of broth macrodilution (Muller-Hinton) was 
used to determine the minimum inhibitory concentration 
(MIC) of plant extracts. In a series of seven hemolytic 
tubes, 1 ml of each extract concentration (80 mg  to  
0.078 mg / ml) was added to each tube containing 1 ml 
of Muller-Hinton broth and germ. The final 
concentration of extract varied between 40 mg / ml and 
0.039 mg / ml. Other two tubes were used as control 
tubes. One for sterility control containing 2ml of 
sterilized broth and other containing 2 ml contaminated 
broth for growth control. The tubes were incubated at 37 
° C for 18 to 24 hours. The MIC determination was 
performed by finding the difference between the 
turbidity values obtained before incubation (di) and those 
obtained after incubation (df) of each tube. These values 
were measured using a turbidimeter  densimat type. 
When df - di = 0 for a given tube then extract 
concentration of the tube corresponds to the MIC.
 
 
 
 
 
 
 
 
Strains   Origin   Antibacterial  profile 
E. coli ATCC 25922 Collection  
 
AMXS AMCS TICS TCCS PIPS CFS FOXS CTXS CAZS ATMS 
GMS TMS KS ANS  NETS TES CSS SXTS NAS PEFS CIPS 
E. coli 28170 ECBU 
 
AMXR PIPR CFR CXMR CMXR TMR NETR TER SXTR NAR PEFR 
NORR GMR 
S. aureus ATCC 25923 Collection  
 
PS AMS AMXS AMCS OXS TICS CTXS GMS KS TMS TES ES SPS 
LS CIPS 
S. aureus 1326 Cathéter central PT
R PR LR ER RAR KR TMR GMR  
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RESULTS AND DISCUSSION  
Table 2: Diameters of inhibition zones in mm extracts of Erigeron floribundus, Heliotropium indicum, 
Acanthospermum spidum, Melanthera scadens and Terminalia mantaly 
 
Table 3: Minimum Inhibitory Concentration (MIC) in mg / ml extracts of Erigeron floribundus, Heliotropium indicum, 
Acanthospermum spidum, Melanthera scadens and Terminalia mantaly 
 Extraits E. coli ATCC 
25922 
E. coli  clinical 
strain 
S. aureus 
ATCC 25923 
S. aureus  clinical 
strain. 
 
Erigeron floribundus Aqueous 
Ethanolic 
> 40 
> 40 
> 40 
> 40 
> 40 
20 
> 40 
> 40 
Heliotropium indicum Aqueous 
Ethanolic 
> 40 
> 40 
> 40 
> 40 
> 40 
> 40 
> 40 
> 40 
Acanthospermum 
hispidum 
Aqueous 
Ethanolic 
> 40 
> 40 
> 40 
> 40 
> 40 
40 
> 40 
> 40 
Melanthera  
Scadens 
Aqueous 
Ethanolic 
> 40 
> 40 
> 40 
> 40 
> 40 
40 
> 40 
> 40 
Terminalia  
Mantaly 
Aqueous 
Ethanolic 
0,625 
0,3125 
2,5 
1,25 
0,3125 
0,078 
1,25 
0,3125 
 
Agar diffusion method revealed that only Terminalia 
mantaly presented inhibitory activity on all strains tested. 
The diameter of the inhibition zones ranged from 7.66 
mm to 29 mm for total aqueous extract and 11.33 mm to 
35 mm for total ethanolic 70% extract (Table 1). The 
highest zones of inhibition are obtained on the strain of 
S. aureus ATCC 25923 and are 29 mm in diameter for 
LYTERaq and 35 mm diameter for LYTEReth. Total 
ethanolic extracts 70% AHeth  Mseth and EFeth showed 
inhibition zones on the strain of S. aureus ATCC 25923 
with diameters of 12.33 mm, 24.66 mm and 28 mm 
respectively. 
The results obtained with the method of double dilution 
in liquid medium confirmed the results obtained above. 
Terminalia mantaly is active in all strains. And that is 
represented by minimum inhibitory concentrations 
(MIC) obtained (Table 2). MIC values  varied from 
0.3125 mg / ml to 2.5 mg / ml for aqueous extract and 
from 0.078 mg / ml to 1.25 mg / ml for total ethanolic 
extract. 
The analysis result shows that Terminalia mantaly has 
the strongest inhibitory activity than the other three 
plants regardless of the method used. No cases of 
resistance have been noted with the different extracts of 
this plant. This is verified by the inhibition diameters 
from 7.66 mm to 36mm and MIC from 0.078mg/ml to 
2.5 mg / ml. Thus MIC obtained with Terminalia 
mantaly are 0.078mg/ml, 0.3125 mg / ml, 0.3125mg/ml 
and 1.25 mg / ml respectively on S. aureus ATCC 25923, 
S. aureus clinical strain,  E. coli ATCC 25922 and E. coli 
clinical strain. The highest MIC (2.5 mg / ml) was 
obtained on the clinical strain of E. coli. These results are 
comprehensive, because according to Baba - Moussa et 
al6 and Mann et al10, most of the families Combretaceae 
species are known to contain antimicrobial compounds. 
Also the antibacterial activity of Terminalia mantaly had 
already been mentioned by Andrianstsoa and 
Andriantsiferana  4. He revealed that the extract from the 
decoction of the leaves and stems of Terminalia mantaly 
inhibited the growth of Shiguella dysenteriae at 
concentration between 600μg/ml and 800μg/ml . Yayé et 
al 16 also showed that the total aqueous extracts and 
ethanolic 70% of this plant showed antifungal activity 
against Candida albicans at concentrations of 97.5 
micrograms / ml and 48.75 micrograms / ml.  
The ethanolic extracts have a better antibacterial activity 
than the aqueous extracts and this regardless of the germ 
and the plant tested. The method of preparation of the 
ethanolic extract by the mixture of ethanol-water solvent 
(70/30) was initiated by Zihiri et al.17 Several studies 
including the Ahon et al.3, Ackah et al.2 and Yayé et al 16 
 Extract E. coli  
ATCC 25922 
E. coli souche 
clinique 
S. aureus 
ATCC 25923 
S. aureus 
souche clinique 
Erigeron 
floribundus 
Aqueous 
Ethanolic 
<10 
<10 
<10 
<10 
<10 
28 
<10 
11±0,57 
Heliotropium 
 indicum 
Aqueous 
Ethanolic 
<10 
<10 
<10 
<10 
<10 
<10 
<10 
<10 
Acanthospermum 
hispidum 
Aqueous 
Ethanolic 
<10 
<10 
<10 
<10 
<10 
12,33±1,52 
<10 
11,33±0,57 
Melanthera  
scadens 
Aqueous 
Ethanolic 
<10 
<10 
<10 
<10 
<10 
24,66±5,03 
<10 
12,33±1,52 
Terminalia  
mantaly 
Aqueous 
Ethanolic 
12 
14,33±0,57 
10,66±0,57 
12,33±0,57 
29±1 
35±1 
23±1 
30,66±1,15 
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showed that ethanol 70%  extract prepared by this 
method is more active than the aqueous extract. Our 
results therefore confirm theirs. This method therefore 
produces a better concentration of active ingredients. 
CONCLUSION 
This study has allowed us to determine the antibacterial 
properties of Erigeron floribundus, Acanthospermum 
hispidum, Melanthera scadens and Terminalia mantaly. 
It shows from these investigations that Terminalia 
mantaly is the most active plant among the four plants 
studied. The most sensitive strains were S. aureus. The 
hydroalcoholic extract (70/30) concentrate most the 
active ingredient of plants studied. Further studies will 
produce a series of chromatography to optimize the 
active ingredients, and determine the chemical 
compounds responsible for the antibacterial activity of 
Terminalia mantaly. 
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